Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Delate

Showing results (131-140 of 155) with videos related to

Pageof 16
Sort By:
Pharmacotherapy|September 29, 2012
Assessment of the association between colchicine therapy and serious adverse eventsBrittany A Todd, Sarah J Billups, Thomas Delate, et al.
Thrombosis Research|November 22, 2021
Clinical outcomes of dabigatran use in patients with non-valvular atrial fibrillation and weight >120 kgJamie Coates, Emily Bitton, Ashley Hendje, et al.
Thrombosis Research|June 27, 2013
Nonadherence with INR monitoring and anticoagulant complicationsDaniel M Witt, Thomas Delate, Nathan P Clark, et al.
The Oncologist|February 16, 2012
Outpatient use of low molecular weight heparin monotherapy for first-line treatment of venous thromboembolism in advanced cancerThomas Delate, Daniel M Witt, Debra Ritzwoller, et al.
Archives of Internal Medicine|September 19, 2012
Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for gastrointestinal tract bleedingDaniel M Witt, Thomas Delate, David A Garcia, et al.
Frontiers in Oncology|March 22, 2014
Diffusion of Intraperitoneal Chemotherapy in Women with Advanced Ovarian Cancer in Community Settings 2003-2008: The Effect of the NCI Clinical RecommendationErin J Aiello Bowles, Karen J Wernli, Heidi J Gray, et al.
Journal of Oncology Practice|June 11, 2015
Use of Bevacizumab in Community Settings: Toxicity Profile and Risk of Hospitalization in Patients With Advanced Non-Small-Cell Lung CancerNikki M Carroll, Thomas Delate, Alex Menter, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 18, 2014
Comparative effectiveness of adjunctive bevacizumab for advanced lung cancer: the cancer research network experienceDebra P Ritzwoller, Nikki M Carroll, Thomas Delate, et al.
Blood|May 15, 2009
Outcomes and predictors of very stable INR control during chronic anticoagulation therapyDaniel M Witt, Thomas Delate, Nathan P Clark, et al.
Heart Rhythm|August 20, 2023
Safety of direct oral anticoagulant use in patients taking verapamil or diltiazemSamantha S M Teshima, Elsie M Casanova, Erin T Drees, et al.
Pageof 16

Showing results (131-140 of 155) with videos related to

Sort By:
Pageof 16
Pharmacotherapy|September 29, 2012
Assessment of the association between colchicine therapy and serious adverse eventsBrittany A Todd, Sarah J Billups, Thomas Delate, et al.
Thrombosis Research|November 22, 2021
Clinical outcomes of dabigatran use in patients with non-valvular atrial fibrillation and weight >120 kgJamie Coates, Emily Bitton, Ashley Hendje, et al.
Thrombosis Research|June 27, 2013
Nonadherence with INR monitoring and anticoagulant complicationsDaniel M Witt, Thomas Delate, Nathan P Clark, et al.
The Oncologist|February 16, 2012
Outpatient use of low molecular weight heparin monotherapy for first-line treatment of venous thromboembolism in advanced cancerThomas Delate, Daniel M Witt, Debra Ritzwoller, et al.
Archives of Internal Medicine|September 19, 2012
Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for gastrointestinal tract bleedingDaniel M Witt, Thomas Delate, David A Garcia, et al.
Frontiers in Oncology|March 22, 2014
Diffusion of Intraperitoneal Chemotherapy in Women with Advanced Ovarian Cancer in Community Settings 2003-2008: The Effect of the NCI Clinical RecommendationErin J Aiello Bowles, Karen J Wernli, Heidi J Gray, et al.
Journal of Oncology Practice|June 11, 2015
Use of Bevacizumab in Community Settings: Toxicity Profile and Risk of Hospitalization in Patients With Advanced Non-Small-Cell Lung CancerNikki M Carroll, Thomas Delate, Alex Menter, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 18, 2014
Comparative effectiveness of adjunctive bevacizumab for advanced lung cancer: the cancer research network experienceDebra P Ritzwoller, Nikki M Carroll, Thomas Delate, et al.
Blood|May 15, 2009
Outcomes and predictors of very stable INR control during chronic anticoagulation therapyDaniel M Witt, Thomas Delate, Nathan P Clark, et al.
Heart Rhythm|August 20, 2023
Safety of direct oral anticoagulant use in patients taking verapamil or diltiazemSamantha S M Teshima, Elsie M Casanova, Erin T Drees, et al.
Pageof 16